Arizona State Retirement System Acquires 217 Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Arizona State Retirement System raised its holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA – Get Rating) by 4.1% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 5,478 shares of the company’s stock after acquiring an additional 217 shares during the quarter. Arizona State Retirement System’s holdings in Establishment Labs were worth $360,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently bought and sold shares of ESTA. Bank of New York Mellon Corp grew its position in Establishment Labs by 22.4% in the 1st quarter. Bank of New York Mellon Corp now owns 18,643 shares of the company’s stock valued at $1,256,000 after acquiring an additional 3,416 shares during the last quarter. Bank of Montreal Can bought a new position in Establishment Labs in the 1st quarter valued at $1,408,000. BlackRock Inc. grew its position in Establishment Labs by 2.5% in the 1st quarter. BlackRock Inc. now owns 90,995 shares of the company’s stock valued at $6,133,000 after acquiring an additional 2,198 shares during the last quarter. Vanguard Group Inc. grew its position in Establishment Labs by 4.3% in the 1st quarter. Vanguard Group Inc. now owns 75,747 shares of the company’s stock valued at $5,104,000 after acquiring an additional 3,154 shares during the last quarter. Finally, Affinity Asset Advisors LLC grew its position in Establishment Labs by 125.2% in the 1st quarter. Affinity Asset Advisors LLC now owns 174,500 shares of the company’s stock valued at $11,760,000 after acquiring an additional 97,000 shares during the last quarter. Institutional investors own 75.26% of the company’s stock.

Insider Buying and Selling at Establishment Labs

In other Establishment Labs news, Director Leslie Gillin sold 3,759 shares of the stock in a transaction dated Wednesday, March 15th. The stock was sold at an average price of $67.62, for a total value of $254,183.58. Following the completion of the sale, the director now directly owns 3,599 shares in the company, valued at $243,364.38. The transaction was disclosed in a document filed with the SEC, which is available at this link. 12.64% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the company. Mizuho increased their price target on Establishment Labs from $95.00 to $110.00 and gave the stock a “buy” rating in a research report on Friday, April 21st. BTIG Research increased their price target on Establishment Labs from $100.00 to $105.00 and gave the stock a “buy” rating in a research report on Monday, April 17th. Finally, Stephens reissued an “overweight” rating and set a $89.00 price target on shares of Establishment Labs in a research report on Friday, April 21st. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $95.20.

Establishment Labs Trading Down 1.1 %

Shares of NASDAQ ESTA opened at $68.62 on Monday. The company has a debt-to-equity ratio of 97.56, a current ratio of 3.43 and a quick ratio of 2.31. The stock has a market capitalization of $1.77 billion, a P/E ratio of -20.73 and a beta of 1.01. Establishment Labs Holdings Inc. has a 1-year low of $44.03 and a 1-year high of $79.88. The business has a fifty day moving average price of $70.28 and a 200 day moving average price of $67.54.

Establishment Labs (NASDAQ:ESTA – Get Rating) last issued its quarterly earnings data on Monday, February 27th. The company reported ($0.55) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.71) by $0.16. The firm had revenue of $43.81 million during the quarter, compared to analysts’ expectations of $43.70 million. Establishment Labs had a negative return on equity of 422.08% and a negative net margin of 47.84%. Equities research analysts expect that Establishment Labs Holdings Inc. will post -2.56 EPS for the current fiscal year.

Establishment Labs Company Profile

(Get Rating)

Establishment Labs Holdings, Inc is a technology company, which engages in the design, development, manufacture, and marketing of silicone breast implants. It generates income from customers in Europe, the Middle East, Latin America, and Asia. The firm’s products include Motiva Implants, Motiva Flora Tissue Expander, Motiva Ergonomix, and Motiva Ergonomix2.